Annual Gross Profit
$106.88 M
+$12.15 M+12.83%
December 1, 2024
Summary
- As of March 12, 2025, ADPT annual gross profit is $106.88 million, with the most recent change of +$12.15 million (+12.83%) on December 1, 2024.
- During the last 3 years, ADPT annual gross profit has risen by +$1.83 million (+1.75%).
- ADPT annual gross profit is now -16.11% below its all-time high of $127.40 million, reached on December 31, 2022.
Performance
ADPT Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$29.41 M
-$354.00 K-1.19%
December 1, 2024
Summary
- As of March 12, 2025, ADPT quarterly gross profit is $29.41 million, with the most recent change of -$354.00 thousand (-1.19%) on December 1, 2024.
- Over the past year, ADPT quarterly gross profit has dropped by -$354.00 thousand (-1.19%).
- ADPT quarterly gross profit is now -23.82% below its all-time high of $38.61 million, reached on December 31, 2022.
Performance
ADPT Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$106.88 M
+$3.25 M+3.13%
December 1, 2024
Summary
- As of March 12, 2025, ADPT TTM gross profit is $106.88 million, with the most recent change of +$3.25 million (+3.13%) on December 1, 2024.
- Over the past year, ADPT TTM gross profit has increased by +$3.25 million (+3.13%).
- ADPT TTM gross profit is now -16.11% below its all-time high of $127.40 million, reached on December 31, 2022.
Performance
ADPT TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
ADPT Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.8% | -1.2% | +3.1% |
| 3 y3 years | +1.8% | -3.4% | +2.1% |
| 5 y5 years | +70.2% | -3.4% | +2.1% |
ADPT Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | +12.8% | -23.8% | +58.4% | -16.1% | +15.6% |
| 5 y | 5-year | -16.1% | +70.2% | -23.8% | +89.0% | -16.1% | +70.2% |
| alltime | all time | -16.1% | +369.4% | -23.8% | +413.7% | -16.1% | +1766.5% |
Adaptive Biotechnologies Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $106.88 M(+12.8%) | $29.41 M(-1.2%) | $106.88 M(+3.1%) |
| Sep 2024 | - | $29.77 M(+24.7%) | $103.63 M(+12.1%) |
| Jun 2024 | - | $23.87 M(+0.2%) | $92.44 M(-7.2%) |
| Mar 2024 | - | $23.82 M(-9.0%) | $99.58 M(+5.1%) |
| Dec 2023 | $94.72 M(-25.6%) | $26.17 M(+40.9%) | $94.72 M(-11.6%) |
| Sep 2023 | - | $18.57 M(-40.1%) | $107.16 M(-11.8%) |
| Jun 2023 | - | $31.02 M(+63.5%) | $121.51 M(+0.5%) |
| Mar 2023 | - | $18.97 M(-50.9%) | $120.94 M(-5.1%) |
| Dec 2022 | $127.40 M(+21.3%) | $38.61 M(+17.3%) | $127.40 M(+13.4%) |
| Sep 2022 | - | $32.92 M(+8.2%) | $112.36 M(+7.3%) |
| Jun 2022 | - | $30.44 M(+19.7%) | $104.72 M(+2.6%) |
| Mar 2022 | - | $25.43 M(+7.9%) | $102.02 M(-2.9%) |
| Dec 2021 | $105.04 M | $23.57 M(-6.7%) | $105.04 M(-0.4%) |
| Sep 2021 | - | $25.28 M(-8.9%) | $105.43 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $27.74 M(-2.5%) | $100.40 M(+13.1%) |
| Mar 2021 | - | $28.45 M(+18.7%) | $88.74 M(+17.0%) |
| Dec 2020 | $75.85 M(+20.8%) | $23.96 M(+18.4%) | $75.85 M(+8.1%) |
| Sep 2020 | - | $20.25 M(+25.9%) | $70.15 M(-0.3%) |
| Jun 2020 | - | $16.08 M(+3.3%) | $70.36 M(-0.5%) |
| Mar 2020 | - | $15.57 M(-14.7%) | $70.69 M(+12.6%) |
| Dec 2019 | $62.80 M(+74.5%) | $18.26 M(-10.7%) | $62.80 M(+11.2%) |
| Sep 2019 | - | $20.46 M(+24.7%) | $56.46 M(+18.0%) |
| Jun 2019 | - | $16.40 M(+113.6%) | $47.83 M(+26.0%) |
| Mar 2019 | - | $7.68 M(-35.6%) | $37.95 M(+5.4%) |
| Dec 2018 | $35.99 M(+58.1%) | $11.92 M(+0.8%) | $35.99 M(+49.5%) |
| Sep 2018 | - | $11.83 M(+81.3%) | $24.08 M(+96.6%) |
| Jun 2018 | - | $6.52 M(+13.9%) | $12.25 M(+113.9%) |
| Mar 2018 | - | $5.73 M | $5.73 M |
| Dec 2017 | $22.77 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual gross profit?
- What is the all time high annual gross profit for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual gross profit year-on-year change?
- What is Adaptive Biotechnologies quarterly gross profit?
- What is the all time high quarterly gross profit for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly gross profit year-on-year change?
- What is Adaptive Biotechnologies TTM gross profit?
- What is the all time high TTM gross profit for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM gross profit year-on-year change?
What is Adaptive Biotechnologies annual gross profit?
The current annual gross profit of ADPT is $106.88 M
What is the all time high annual gross profit for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual gross profit is $127.40 M
What is Adaptive Biotechnologies annual gross profit year-on-year change?
Over the past year, ADPT annual gross profit has changed by +$12.15 M (+12.83%)
What is Adaptive Biotechnologies quarterly gross profit?
The current quarterly gross profit of ADPT is $29.41 M
What is the all time high quarterly gross profit for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly gross profit is $38.61 M
What is Adaptive Biotechnologies quarterly gross profit year-on-year change?
Over the past year, ADPT quarterly gross profit has changed by -$354.00 K (-1.19%)
What is Adaptive Biotechnologies TTM gross profit?
The current TTM gross profit of ADPT is $106.88 M
What is the all time high TTM gross profit for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM gross profit is $127.40 M
What is Adaptive Biotechnologies TTM gross profit year-on-year change?
Over the past year, ADPT TTM gross profit has changed by +$3.25 M (+3.13%)